Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Avodart introduced in U.K.

March 11, 2003

Levitra approved in E.U.

March 11, 2003

Columbia and Quintiles establish Striant commercialization agreement

March 10, 2003

Approvable letter for Fosrenol

March 5, 2003

FDA approves Oxytrol for overactive bladder

March 3, 2003

Results of AVI-4126 in PKD patients

Feb. 28, 2003

New PDE5 inhibitors in early development at Tanabe Seiyaku

Feb. 20, 2003

YC-1 increases the incidence of penile erection in rats

Feb. 18, 2003

New PDE5 inhibitors identified by Lilly Icos team

Feb. 6, 2003

Ferring researchers identify new oxytocin agonists

Feb. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...